Skip to Main Content
Don't have an account? Create Account

Siegel: 340B Guidance at Odds with HHS Policy Goals

In a new commentary on proposed 340B Drug Pricing Program guidance, America’s Essential Hospitals President and CEO Bruce Siegel, MD, MPH, says the guidance conflicts with Obama administration goals for readmissions, health care access, and care coordination.

In working toward these goals, Siegel wrote in a May 7 Modern Healthcare column, U.S. Department of Health and Human Services Secretary Sylvia Mathews Burwell “might be fighting a headwind of her department’s own making” – proposed omnibus guidance on the 340B program from the Health Resources and Services Administration.

That guidance, published Aug. 28, 2015, not only threatens patient access to affordable drugs under the 340B program, but “could undermine administration initiatives to reduce hospital readmissions, expand access to care, and tackle social determinants of health that plague vulnerable populations.”

Siegel’s commentary complements a recent association graphic that illustrates how the proposed guidance would reduce access through changes to patient and facility eligibility. In Oct. 27, 2015, comments, America’s Essential Hospitals argued extensively against making the proposed guidance final. The association also hosted Capitol Hill round-table discussions earlier this year to educate lawmakers and staff about the harm the guidance would cause.



About the Author

Graziano is senior director of communications for America's Essential Hospitals.

Previous Next
Test Caption
Test Description goes like this